Latest Retina News
Panorama Study For Patients With Diabetic Retinopathy
Clinical Trial for Patients with NPDR Dear Respected Colleague, We are pleased to inform you that CFR is participating as a recruiting study site in the Regeneron Pharmaceuticals, Inc. PANORAMA study: a phase 3 study of the efficacy and safety of intravitreal (IVT) aflibercept in patients with moderately severe to severe NPDR. Approximately 360 patients […]
Read MoreCFR Welcomes Dr. Gokul N. Kumar
Central Florida Retina is proud to welcome Gokul N. Kumar, M.D.
Read MoreLeading The Way In Clinical Research
Our highly skilled and dedicated research team is pleased to announce that we are currently recruiting patients for the following studies. Regeneron: Designed for diabetic retinopathy patients by using intravitreal injection of a anti-VEGF product. To join the study, patients must Have type 1 or type 2 diabetes mellitus Be confirmed to have moderately severe […]
Read More
NOV News: Dinner Symposium and New Specialist
Central Florida Retina Newsletter, November, 2014
Read MoreThe First Bionic Eye To Ever Be Implanted In The US
Retina surgeons at the University of Michigan Kellogg Eye Center have performed the first — and second — surgeries in the United States to implant an artificial retina, or “bionic eye,” since the U.S. Food and Drug Administration approved the device last year.
Read MoreScientists Discover Critical Gene In Retinal Development And Motion Sensing
Scientists have discovered a gene that guides the separation of two types of motion-sensing cells, offering insight into how cellular layering develops in the retina, with possible implications for the brain’s cerebral cortex. A report on the discovery is published in the Nov. 1 issue of the journal Science. “The separation of different types of […]
Read More
